GFS, PETS and CYTK Are Among After Hour Movers

Seeking AlphaMay 22 16:10

Sana Biotechnology Highlights Publication in Nature Biotechnology of Novel In Vivo Preclinical Data Showing the Potential for Pluripotent Stem Cell-Derived Human Glial Progenitor Cell Transplantation as a Treatment for Huntington's Disease and Other...

Globe NewswireMay 21 08:00

Bank of America Securities Remains a Buy on Sana Biotechnology (SANA)

TipRanksMay 13 10:05

HC Wainwright & Co. Reiterates Buy on Sana Biotechnology, Maintains $12 Price Target

HC Wainwright & Co. analyst Emily Bodnar reiterates Sana Biotechnology (NASDAQ:SANA) with a Buy and maintains $12 price target.

BenzingaMay 9 14:22

Sana Biotechnology Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/09/2024 59.36% HC Wainwright & Co. → $12 Reiterates Buy → Buy 03/01/2024 99.21% JMP Securities $8 → $15

BenzingaMay 9 14:21

Sana Biotechnology Shares Are Trading Lower After the Company Reported Q1 Financial Results.

Sana Biotechnology Shares Are Trading Lower After the Company Reported Q1 Financial Results.

BenzingaMay 9 12:53